Study of PHN131 in Healthy Volunteers
NCT02192151 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2025-06-06
Summary
To evaluate the safety and to investigate the pharmacokinetic properties and bioavailability of PHN131 in healthy volunteers
Conditions
- Analgesia Disorder
Sponsors & Collaborators
-
PhytoHealth Corporation
lead INDUSTRY
Principal Investigators
-
Shung-Tai Ho, Ph.D · Tri-service General Hospital & National Defense Medical Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2011-10-31
- Completion
- 2012-10-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers
NCT03129347 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Ketamine Administered Intravenously and by Sublingual Wafer
NCT01377831 ·Status: COMPLETED
-
Long Term Safety of Naldemedine
NCT01965652 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers
NCT02750748 ·Status: COMPLETED ·Phase: PHASE1
-
The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial
NCT06785571 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects
NCT02083315 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Evaluation of Intranasal Nalmefene
NCT04759768 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain
NCT04713189 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
NCT00214955 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study on the Patients With Pain Medications
NCT00771212 ·Status: COMPLETED
-
Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain
NCT00415597 ·Status: COMPLETED ·Phase: PHASE3
-
Dosing Intervals of Opioid Medication for Chronic Pain
NCT04132011 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
NCT01428583 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
NCT00647127 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Controlled Administration of Liquid Acetaminophen
NCT06498713 ·Status: RECRUITING ·Phase: PHASE1
-
Pharmacokinetic Profile of OROS Hydromorphone in Healthy Taiwanese Participants With Different Genotypes for the UGT2B7 Gene
NCT01487564 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects
NCT01322360 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).
NCT01750060 ·Status: COMPLETED ·Phase: PHASE1
-
Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
NCT07110051 ·Status: RECRUITING ·Phase: NA
-
An Exploratory Study of Tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back Pain
NCT00752661 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics
NCT00216684 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back Pain
NCT05170841 ·Status: COMPLETED ·Phase: PHASE4
-
A Single Dose Study of SHR0410 in Healthy Male Participants
NCT03493191 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
NCT01571362 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Dose on the Pharmacokinetics of OROS Hydromorphone Under Fasted Conditions in Healthy Taiwanese Participants
NCT01487512 ·Status: COMPLETED ·Phase: PHASE1